Laddar...
WHODAS 2.0 in prodromal Huntington disease: measures of functioning in neuropsychiatric disease
Clinical trials to improve day-to-day function in Huntington disease (HD) require accurate outcome measures. The DSM-5 recommends the World Health Organization Disability Assessment Schedule (WHODAS) 2.0 for use in neuropsychiatric disorders. The DSM-5 also states proxy measures may be useful when c...
Sparad:
| I publikationen: | Eur J Hum Genet |
|---|---|
| Huvudupphovsmän: | , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Nature Publishing Group
2014
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4350592/ https://ncbi.nlm.nih.gov/pubmed/24327189 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ejhg.2013.275 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|